230 related articles for article (PubMed ID: 31072737)
1. Clinical characteristics and long term follow-up of Lambert-Eaton myasthenia syndrome in patients with and without small cell lung cancer.
Liu Y; Xi J; Zhou L; Wu H; Yue D; Zhu W; Lin J; Lu J; Zhao C; Qiao K
J Clin Neurosci; 2019 Jul; 65():41-45. PubMed ID: 31072737
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.
Lipka AF; Boldingh MI; van Zwet EW; Schreurs MWJ; Kuks JBM; Tallaksen CM; Titulaer MJ; Verschuuren JJGM
Neurology; 2020 Feb; 94(5):e511-e520. PubMed ID: 31831596
[TBL] [Abstract][Full Text] [Related]
3. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
4. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Grainge MJ; Lang B
Neurology; 2017 Apr; 88(14):1334-1339. PubMed ID: 28251917
[TBL] [Abstract][Full Text] [Related]
6. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
[TBL] [Abstract][Full Text] [Related]
7. Lambert-Eaton myasthenic syndrome in patients with small cell lung cancer: Report of five cases.
Hao Y; Hu J; Zhang Y; Liu W; Lu S; Zhang M
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C95-6. PubMed ID: 26323934
[TBL] [Abstract][Full Text] [Related]
8. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
Wirtz PW; Willcox N; van der Slik AR; Lang B; Maddison P; Koeleman BP; Giphart MJ; Wintzen AR; Roep BO; Verschuuren JJ
J Neuroimmunol; 2005 Feb; 159(1-2):230-7. PubMed ID: 15652424
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.
Wirtz PW; Nijnuis MG; Sotodeh M; Willems LN; Brahim JJ; Putter H; Wintzen AR; Verschuuren JJ;
J Neurol; 2003 Jun; 250(6):698-701. PubMed ID: 12796832
[TBL] [Abstract][Full Text] [Related]
10. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
Titulaer MJ; Maddison P; Sont JK; Wirtz PW; Hilton-Jones D; Klooster R; Willcox N; Potman M; Sillevis Smitt PA; Kuks JB; Roep BO; Vincent A; van der Maarel SM; van Dijk JG; Lang B; Verschuuren JJ
J Clin Oncol; 2011 Mar; 29(7):902-8. PubMed ID: 21245427
[TBL] [Abstract][Full Text] [Related]
11. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
12. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
13. The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
Titulaer MJ; Wirtz PW; Kuks JB; Schelhaas HJ; van der Kooi AJ; Faber CG; van der Pol WL; de Visser M; Sillevis Smitt PA; Verschuuren JJ
J Neuroimmunol; 2008 Sep; 201-202():153-8. PubMed ID: 18644631
[TBL] [Abstract][Full Text] [Related]
14. SOX-1 antibodies positive Lambert-Eaton myasthenic syndrome with occult small cell lung cancer: A case report.
Zhao L; He H; Han W; Meng Y; Kang L; Chen Y
Clin Respir J; 2024 Mar; 18(3):e13740. PubMed ID: 38497229
[TBL] [Abstract][Full Text] [Related]
15. Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families.
Wirtz PW; Bradshaw J; Wintzen AR; Verschuuren JJ
J Neurol; 2004 Oct; 251(10):1255-9. PubMed ID: 15503107
[TBL] [Abstract][Full Text] [Related]
16. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
Maddison P; Lang B; Mills K; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):212-7. PubMed ID: 11160470
[TBL] [Abstract][Full Text] [Related]
17. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
18. [Lambert-Eaton myasthenic syndrome].
Motomura M; Fukuda T
Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of 12 Korean Lambert-Eaton myasthenic syndrome (LEMS) patients.
Moon JS; Sunwoo IN; Kim SM; Lee SA; Cho KH; Park KD; Kim WK; Choi BO; Chun HY
Yonsei Med J; 1999 Oct; 40(5):454-9. PubMed ID: 10565256
[TBL] [Abstract][Full Text] [Related]
20. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
